Back to search

Aristotle University Of Thessaloniki (AUTH)

Μελέτη της επίδρασης της σιταγλιπτίνης σε πειραματικό μοντέλο διαβητικής νεφροπάθειας

Abstract

dc:description

Dipeptidyl peptidase-4 (DPP-IV) inhibitors have been used more than 10 years as medicines to regulate blood sugar levels in patients with diabetes. Since diabetes is a disease that causes microvascular and macrovascular complications and it is totally associated with atherosclerotic cardiovascular disease and the occurrence of nephropathy, the scientific interest is focused on the effect of these drugs on the complications of the disease. This paper studies the effect of low-dose of sitagliptin treatment (10mg/kg) and high-dose (200mg/kg) on mice BKS. Cg-+Leprdb/+ Lepr+/OlaHsd. This study indicates the effect on biochemical parameters of renal function and on lipids (glucose, urea, creatinine, cholesterol, LDL, HDL, triglycerides, CRP) and on urinary albumin excretion [urinary creatinine , urinary albumin and the albumin/creatinine ratio (ACR)]. The effect of the drug on kidney histopathology, and the glomerular lesions were also assessed as the number of glomeruli that exhibited the lesion/total number of glomeruli. It was found that high dose of sitagliptin resulted in statistically significant reduction of glucose (p<0.0001), urinary albumin (p=0.013) and urinary albumin/creatinine ratio (p<0.0001). In the high dose sitagliptin group there was a statistically significant improvement in the growth of the extracellular matrix (ECM) of mesangium (p<0.0001), in the glomerulosclerosis index (p<0.0001), in the thickening of the glomerular basement membrane (p=0.020) and a decrease of the number of glomeruli with hyalinosis of the glomerulus (p=0.042). The effect of the drug was evident only in the glomeruli. The lesions in the interstitial space and in the renal tubules were absent in all experimental groups. Finally, CRP and cholesterol had a decreasing trend (not statistically significant) in the high-dose of sitagliptin group (p = 0.057 for cholesterol, p = 0.099 for CRP). In conclusion, it appears that administration of sitagliptin reduces urinary albumin and there is possibility to exert a favorable effect on the histopathological image of the kidney in this particular experimental model. Large multicenter research programmes on humans should study possible beneficial effects.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2018

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Tsavdaridis, Ioannis
  • Τσαβδαρίδης, Ιωάννης

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/43044

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Tsavdaridis, Ioannis; Τσαβδαρίδης, Ιωάννης. Μελέτη της επίδρασης της σιταγλιπτίνης σε πειραματικό μοντέλο διαβητικής νεφροπάθειας. Aristotle University Of Thessaloniki (AUTH), 2018. http://hdl.handle.net/10442/hedi/43044